Question 1

What is the catalog number for HA14-1?

Accepted Answer

The catalog number for HA14-1 is C16088-25mg.

Question 2

What sizes are available for HA14-1?

Accepted Answer

HA14-1 is available in the following size(s): 25 mg.

Question 3

Is HA14-1 in stock?

Accepted Answer

HA14-1 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Are there any special shipping requirements for HA14-1?

Accepted Answer

HA14-1 is requires dry ice shipping.

Question 5

What should I check when this product first arrives?

Accepted Answer

Inspect the package immediately for transportation damage, ice loss, leakage, or breakage. Report any issues right away with photos and your order reference; our specialists will determine whether the product is still usable or needs replacing.

Question 6

Does this cell line or biologic require a Material Transfer Agreement (MTA)?

Accepted Answer

Some products, including certain cell lines, plasmids, and tissue cultures, are subject to intellectual property terms and may require an MTA before we can ship. We’ll inform you in advance if this product requires one, and additional handling fees may apply.

Question 7

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

HA14-1

Product Specifications

CAS Number

Target

Applications

Smiles

Molecular Formula

Additionnal Information

Storage Conditions

Frequently Asked Questions

Explore Other Products

RTDR1 (Rhabdoid Tumor Deletion Region Protein 1) (MaxLight 490)

RTDR1 (Rhabdoid Tumor Deletion Region Protein 1) (MaxLight 490)

COPE Rabbit Polyclonal Antibody (Biotin)

TFCP2 (Alpha-globin Transcription Factor CP2, SAA3 Enhancer Factor, Transcription Factor LSF, LSF, SEF) (AP) discontinued

Ziyuglycoside I discontinued

ANXA4 (HRP)